Abstract 3261: EOS100850, a non-brain penetrant highly selective A2Areceptor antagonist, uniquely maintains high potency within the adenosine rich tumor microenvironment by Houthuys, Erica, Basilico, Paola, Brouwer, Margreet, Deregnaucourt, Theo, Detheux, Michel, Driessens, Gregory, Gomes, Bruno, Leroy, Xavier, Marchante, Joao, Marillier, Reece, Swiercz, Jakub, Crosignani, Stefano

Get full text

Abstract 1683: A novel adenosine A2A receptor antagonist optimized for high potency in adenosine-rich tumor microenvironment boosts antitumor immunity by Houthuys, Erica, Brouwer, Margreet, Nyawouame, Florence, Pirson, Romain, Marillier, Reece, Deregnaucourt, Theo, Marchante, Joao, Swiercz, Jakub, Moulin, Charlotte, Bol, Vanesa, Driessens, Gregory, Detheux, Michel, Quéva, Christophe, Crosignani, Stefano, Gomes, Bruno

Get full text

Abstract LB-291: EOS100850, an insurmountable and non-brain penetrant A2A receptor antagonist, inhibits adenosine-mediated T cell suppression, demonstrates anti-tumor activity and... by Houthuys, Erica, Marillier, Reece, Deregnaucourt, Théo, Brouwer, margreet, Basilico, Paola, Pirson, Romain, Marchante, Joao, Prasad, Shruthi, Hermant, Annelise, Nyawouame, Florence, Preillon, Julie, Frederix, Kim, Michaux, Anne Catherine, Lambolez, Florence, Swiercz, Jakub, Driessens, Gregory, Wald, Noemie, Martinoli, Chiara, Bodo, Veronique, Detheux, Michel, Leroy, Xavier, Crosignani, Stefano

Get full text